ArticleEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology2026
Direct identification and susceptibility testing of positive blood cultures: a large-scale evaluation of an ammonium chloride-based in-house workflow.
Article in European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- A review of bloodstream infections-pathogens, pathogenesis, diagnostic strategies, treatment methods-challenges and future aspects.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
purposePreviously, we reported an ammonium chloride-based in-house rapid workflow for direct pathogen identification and antibiotic susceptibility testing from positive blood cultures, eliminating the need for the following overnight subculture. Here, we aimed to assess the workflow’s reliability, accuracy, and potential for integration into routine clinical practice.
methodsFrom 2018 to 2022, 1,686 monomicrobial positive blood cultures were processed by the rapid workflow: ammonium chloride lysis/centrifugation/wash followed by MALDI-TOF MS identification and, when indicated, same-day VITEK-2 direct antibiotic susceptibility testing. Results were compared with routine culture-based identification and antibiotic susceptibility testing.
resultsThe overall agreement between in-house rapid workflow and conventional culture-based methods was 92.59%. Direct antibiotic susceptibility testing using VITEK 2 on 384 gram-negative and 126 gram-positive isolates showed very major, major, and minor error rates of 0.02%, 0.02%, and 1.14% for gram-negative bacteria, and 0.77%, 0.51%, and 1.09% for gram-positive bacteria. In addition, our IH rapid workflow significantly decreased 22.97 h to pathogen identification and 25.3 h to AST results.
conclusionOver five years, our in-house rapid workflow demonstrated reliable performance for pathogen direct identification and antibiotic susceptibility testing from positive blood cultures. The findings suggest that our rapid workflow has the potential to replace the subculturing of positive blood culture isolates to agar plates for definitive identification and antibiotic susceptibility testing. This could be a significant step forward in improving the efficiency and effectiveness of diagnosing and treating bloodstream infections.
Indexed as
Identifiers
41571949What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.